2017
DOI: 10.1186/s12936-017-1781-4
|View full text |Cite
|
Sign up to set email alerts
|

A novel in vitro model reveals distinctive modulatory roles of Plasmodium falciparum and Plasmodium vivax on naïve cell-mediated immunity

Abstract: BackgroundTo date, human peripheral blood mononuclear cells (PBMCs) have been used mainly in immune stimulation assays and the interpretation of data can be influenced by the previous immunological history of donors and cross reactivity with other infectious agents. Resolving these limitations requires an alternative in vitro model to uncover the primary response profiles.MethodsA novel in vitro model of mononuclear cells (MNCs) generated from haematopoietic stem cells (HSCs) was developed and these cells were… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 33 publications
0
4
0
Order By: Relevance
“…The donors' immunological histories could influence this strong heterogeneous response because these PBMCs could present cross-reactivity with other infections such as schistosomiasis, leishmaniosis, toxoplasmosis, and Chagas disease. For this reason, other authors have proposed alternatives to the use of PBMCs in studying the primary immune response; one such alternative are hematopoietic stem cells (naïve cells), which would reduce the discrepancies in mononuclear cell quality between studies (Chitsanoor et al, 2017).…”
Section: Pbmcs In Other Apicomplexan Parasitesmentioning
confidence: 99%
See 1 more Smart Citation
“…The donors' immunological histories could influence this strong heterogeneous response because these PBMCs could present cross-reactivity with other infections such as schistosomiasis, leishmaniosis, toxoplasmosis, and Chagas disease. For this reason, other authors have proposed alternatives to the use of PBMCs in studying the primary immune response; one such alternative are hematopoietic stem cells (naïve cells), which would reduce the discrepancies in mononuclear cell quality between studies (Chitsanoor et al, 2017).…”
Section: Pbmcs In Other Apicomplexan Parasitesmentioning
confidence: 99%
“…The evidence suggests that PBMCs could be a good model for studying the immune response in apicomplexan parasites and for evaluating the efficiency of vaccine candidates, therapeutic agents and immunomodulatory molecules. However, these cells are not the most appropriate model for studying primo-infections (Chitsanoor et al, 2017). Therefore, despite all the benefits of the PBMC model, precautions should be taken related to its limitations and the type of immune response that is being evaluated.…”
Section: Pbmcs In Other Apicomplexan Parasitesmentioning
confidence: 99%
“…Exposure to P. falciparum iRBCs also alters monocyte activation. It resulted in upregulation of HLA-DR expression on naïve monocytes derived from haematopoietic stem cells (32). Monocytes from PBMCs of Papua New Guinean children with severe malaria responded in vitro to P. falciparum iRBCs by secreting higher quantities of TNF-α, MIP-1β, and MIP-1α (implicated in monocyte activation and recruitment) than healthy children or children with uncomplicated malaria (33).…”
Section: Roles Of Monocytesmentioning
confidence: 99%
“…This is consistent with training or tolerance effects that could explain the contradictory behavior of monocytes observed across different settings, independent of differences in protocols and analysis. To minimize these discrepancies, Udomsangpetch et al have developed a model of mononuclear cells generated from hematopoietic stem cells, that evaluates in vitro the interaction between naïve immune cells and malaria parasites (32). Whole genome association studies (GWAS) might be used as a tool to identify genetic differences that can further explain why monocytes respond differently across geographical areas (103, 104).…”
Section: Future Directionsmentioning
confidence: 99%